Literature DB >> 3148595

Production of parathyroid hormone-related protein in adult T-cell leukemia cells.

S Honda1, K Yamaguchi, Y Miyake, N Hayashi, N Adachi, K Kinoshita, O Ikehara, S Kimura, T Kinoshita, K Shimotohno.   

Abstract

Human parathyroid hormone-related protein (PTHrP) mRNA was detected in peripheral leukemic cells obtained from adult T-cell leukemia (ATL) patients as well as in cultured human T-cell leukemia virus type I (HTLV-I)-infected T-cell lines. In contrast, PTHrP mRNA was not detected in other types of leukemic cells. Using radioimmunoassay, immunoreactive PTHrP was also detected in the spent media of HTLV-I-infected T-cell lines. These results suggest that PTHrP plays an important role in developing the hypercalcemia frequently observed in ATL patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148595      PMCID: PMC5917667          DOI: 10.1111/j.1349-7006.1988.tb01554.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes.

Authors:  W A SKOOG; W S BECK
Journal:  Blood       Date:  1956-05       Impact factor: 22.113

2.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

3.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

Authors:  R Gallagher; S Collins; J Trujillo; K McCredie; M Ahearn; S Tsai; R Metzgar; G Aulakh; R Ting; F Ruscetti; R Gallo
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

4.  Hypercalcemia associated with T-cell lymphoma-leukemia.

Authors:  B Grossman; G P Schechter; J E Horton; L Pierce; E Jaffe; L Wahl
Journal:  Am J Clin Pathol       Date:  1981-02       Impact factor: 2.493

5.  Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.

Authors:  K Kinoshita; S Kamihira; S Ikeda; Y Yamada; T Muta; T Kitamura; M Ichimaru; T Matsuo
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

6.  A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; Y Shiraishi
Journal:  Gan       Date:  1981-12

7.  Hypercalcemia and osteoclast proliferation in adult T-cell leukemia.

Authors:  T Kiyokawa; K Yamaguchi; M Takeya; K Takahashi; T Watanabe; T Matsumoto; S Y Lee; K Takatsuki
Journal:  Cancer       Date:  1987-03-15       Impact factor: 6.860

8.  Interleukin 1 gene expression in adult T cell leukemia.

Authors:  Y Wano; T Hattori; M Matsuoka; K Takatsuki; A O Chua; U Gubler; W C Greene
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  Ph1-positive CML-derived myeloid-monocytoid precursor cell line producing substance(s) that stimulates normal CFU-C.

Authors:  T Mori; S Nakazawa; K Nishino; K Sugita; K Takane; M Mori; K Sagawa; Y Hayashi; M Sakurai
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

10.  Production of bone-resorbing activity corresponding to interleukin-1 alpha by adult T-cell leukemia cells in humans.

Authors:  F Shirakawa; U Yamashita; Y Tanaka; K Watanaba; K Sato; J Haratake; T Fujihira; S Oda; S Eto
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more
  9 in total

Review 1.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

2.  Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.

Authors:  Nicole A Kohart; Said M Elshafae; Aylin A Demirer; Wessel P Dirksen; Justin T Breitbach; Sherry T Shu; Jingyu Xiang; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2019-10-08

3.  Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.

Authors:  Nicholas Polakowski; Heather Gregory; Jean-Michel Mesnard; Isabelle Lemasson
Journal:  Retrovirology       Date:  2010-07-23       Impact factor: 4.602

4.  Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1.

Authors:  J Dittmer; S D Gitlin; R L Reid; J N Brady
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.

Authors:  T Watanabe; K Yamaguchi; K Takatsuki; M Osame; M Yoshida
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

6.  Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.

Authors:  Masachika Senba; Kioko Kawai; Naoki Mori
Journal:  Leuk Res Treatment       Date:  2011-12-01

7.  Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia.

Authors:  Y Miyake; K Yamaguchi; S Honda; K Nagasaki; T Tsuchihashi; M Mori; S Kimura; K Abe
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

8.  Enhancing effect of interleukin-2 on production of parathyroid hormone-related protein by adult T-cell leukemia cells.

Authors:  N Mori; K Ohsumi; S Murakami; A Wake; F Shirakawa; I Morimoto; S Oda; S Eto
Journal:  Jpn J Cancer Res       Date:  1993-04

9.  A case of leiomyosarcoma associated with humoral hypercalcemia of malignancy: demonstration of biological and immunological activities of parathyroid hormone-related protein in the tumor extract.

Authors:  N Nagata; J Takeda; N Kugai; H Kimoto; S Tomimatsu; O Takatani; K Suzuki; Y Fuse; T Tsuchihashi; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1989-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.